Literature DB >> 3180049

L-ascorbic acid amplification of second-stage bladder carcinogenesis promotion by NaHCO3.

S Fukushima1, K Imaida, M A Shibata, S Tamano, Y Kurata, T Shirai.   

Abstract

The dose dependence of NaHCO3 promotion of urinary bladder carcinogenesis and the effects of additional L-ascorbic acid (AsA) administration were investigated subsequent to initiation. Male F344 rats were given 0.05% N-butyl-N-(4-hydroxybutyl)nitrosamine in their drinking water for 4 weeks and then, starting 3 days after cessation of carcinogen treatment, received basal diet containing NaHCO3 at levels of 0, 0.375, 0.75, 1.5, and 3.0% with or without a 5% AsA supplement for 32 weeks. NaHCO3 dose-dependently increased the incidence and numbers of urinary bladder carcinomas in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine. 5% AsA, while itself exerting no promoting effect, amplified the enhancing influence of NaHCO3 on induction of urinary bladder carcinomas. The same dose-dependent elevation of urinary pH and Na+ concentration was associated with NaHCO3 treatment with or without AsA. NaHCO3 significantly increased DNA synthesis in the urinary bladder epithelium and the additional treatment with AsA was associated with a significant further elevation. Thus, increased urinary pH and Na+ concentrations appear to play important roles in NaHCO3 promotion and AsA amplified this promotion. NaHCO3 treatment, with or without AsA, induced cellular proliferation, although it is unclear whether this is an essential factor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3180049

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

Review 1.  Ascorbate on cell growth and differentiation.

Authors:  F J Alcaín; M I Burón
Journal:  J Bioenerg Biomembr       Date:  1994-08       Impact factor: 2.945

2.  Quantitative trait loci associated with promoting effects of sodium L-ascorbate on two-stage bladder carcinogenesis in rats.

Authors:  T Kamoto; S Mori; T Murai; Y Yamada; S Makino; O Yoshida; H Hiai
Journal:  Jpn J Cancer Res       Date:  1997-07

3.  Promotion by sodium L-ascorbate in rat two-stage urinary bladder carcinogenesis is dependent on the interval of administration.

Authors:  T X Chen; H Wanibuchi; T Murai; M Kitano; S Yamamoto; S Fukushima
Journal:  Jpn J Cancer Res       Date:  1999-01

4.  Inhibitory effect of tomato juice on rat urinary bladder carcinogenesis after N-butyl-N-(4-hydroxybutyl)nitrosamine initiation.

Authors:  E Okajima; M Tsutsumi; S Ozono; H Akai; A Denda; H Nishino; S Oshima; H Sakamoto; Y Konishi
Journal:  Jpn J Cancer Res       Date:  1998-01

5.  Lack of promoting effects of alpha-linolenic, linoleic or palmitic acid on urinary bladder carcinogenesis in rats.

Authors:  M Kitano; S Mori; T Chen; T Murai; S Fukushima
Journal:  Jpn J Cancer Res       Date:  1995-06

6.  Synergism of environmental carcinogens and promoters on bladder cancer development initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine in F344 rats.

Authors:  S Ono; Y Kurata; Y Shichino; M Sano; S Fukushima
Journal:  Jpn J Cancer Res       Date:  1992-09

7.  Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  J L de Camargo; T Shirai; T Kato; M Asamoto; S Fukushima
Journal:  Jpn J Cancer Res       Date:  1991-11

8.  Sex differences in o-phenylphenol and sodium o-phenylphenate rat urinary bladder carcinogenesis: urinary metabolites and electrolytes under conditions of aciduria and alkalinuria.

Authors:  R Hasegawa; M Fukuoka; T Takahashi; A Yamamoto; S Yamaguchi; M A Shibata; A Tanaka; S Fukushima
Journal:  Jpn J Cancer Res       Date:  1991-06

9.  The modifying effects of indomethacin or ascorbic acid on cell proliferation induced by different types of bladder tumor promoters in rat urinary bladder and forestomach mucosal epithelium.

Authors:  M A Shibata; S Fukushima; E Asakawa; M Hirose; N Ito
Journal:  Jpn J Cancer Res       Date:  1992-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.